USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Gyrus Medical Limited

USPTO PatentsView assignee record - 81 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Gyrus ranks #4,382 of 49,997 tracked US assignees by granted-patent volume, with 81 patents across 10 technology areas.

#4,382
of 49,997 US assignees by volume
Top 46%
by Innovation Score (36.5/100)
13.2
avg claims per patent
+3%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4382 · Foreign Corporation #4,382 · 81 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 81 grants
  • TOP-DECILE #4,382/49,997
  • PHOTO-FINISH Dinkle Enterprise
  • CPC-FOCUS A61B · 10 areas
  • INNOV-THIN 36.5/100
  • CLAIMS-RICH 13.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT +3% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dinkle Enterprise Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gyrus’s 36.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Gyrus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Gyrus's Innovation Score is 36.5/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Gyrus?

Each dot is one of Gyrus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gyrus’s own 13.2 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Gyrus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 80.981.081.08181.081.081.1 0510152025 Granted patents (volume) Avg claims / patent Dinkle Enterprise Co., Ltd. - 81, 9.4Dinkle EnterpriseECO Holding 1 GmbH - 81, 13.11ECO Holding 1Eagle Harbor Technologies, Inc. - 81, 20.6Eagle HarborFRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NÜRNBERG - 81, 18.6Friedrich-alexand…Griffin Technology, LLC - 81, 4.56Griffin TechnologyHydrangea Breeders Association B.V. - 81, 1Hydrangea Breeder…Hisense Mobile Communications Technology Co., Ltd. - 81, 13.65Hisense Mobile Co…Korrus, Inc. - 81, 15.64KorrusGyrus Medical Limited - 81, 13.17Gyrus Medical
Gyrus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gyrus's grants concentrate

Gyrus Medical Limited is a focused PatentsView assignee: 10 CPC subclasses with 95.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (16 grants) versus a trough of 4 in 2023. By volume, Gyrus sits between Dinkle Enterprise Co., Ltd. and Korrus, Inc..

Gyrus's three-year grant acceleration

From 2019–2021 to 2022–2024, Gyrus Medical Limited moved from 40 to 13 grants (0.33x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Gyrus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Gyrus holds 81 patents at rank #4,380, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Gyrus

By rank, the assignees closest to #4,380 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Gyrus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Gyrus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Gyrus ranks #239 of 7,127 assignees by patent count in that subclass.

Gyrus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 46% higher than 54% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Gyrus Medical Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 6.2%
2016 8 9.9%
2017 6 7.4%
2018 5 6.2%
2019 14 17.3%
2020 16 19.8%
2021 10 12.3%
2022 5 6.2%
2023 4 4.9%
2024 4 4.9%
2025partial year 4 4.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Gyrus Medical Limited's patent record in context - here's where to go next.

  • Gyrus Medical Limited's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 95.1% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #4,382 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Gyrus Medical Limited against Dinkle Enterprise Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.